Cart
sales@molnova.com
MOG (35-55)
CAS No. 149635-73-4
MOG (35-55)( —— )
Catalog No. M20923 CAS No. 149635-73-4
MOG (35-55) is a truncated peptide derived from the human Myelin Oligodendrocyte Glycoprotein (MOG).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 148 | In Stock |
|
| 10MG | 227 | In Stock |
|
| 25MG | 372 | In Stock |
|
| 50MG | 555 | In Stock |
|
| 100MG | 792 | In Stock |
|
| 200MG | 1088 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMOG (35-55)
-
NoteResearch use only, not for human use.
-
Brief DescriptionMOG (35-55) is a truncated peptide derived from the human Myelin Oligodendrocyte Glycoprotein (MOG).
-
DescriptionMOG (35-55) is a truncated peptide derived from the human Myelin Oligodendrocyte Glycoprotein (MOG).
-
In VitroMyelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (MOG (35-55); 0-50 μg/mL; 72 h; lymph nodes cells) induces T?cell proliferative and secretes Th1 cytokines including IFN-γ, TNF-α, IL-10, IL-4 and IL-5. Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat increases the level of IgG.
-
In VivoAnimal Model:HLA-DR2 (DRB1*1501) mice Dosage:200 μg (0.2 mL)Administration:Intraperitoneal injection; once, for 38 days Result:Resulted in paralysis of both hind and forelimbs.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number149635-73-4
-
Formula Weight2581.95
-
Molecular FormulaC118H177N35O29S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCSCCC(N)C(=O)NC(CCC(=O)O)C(=O)NC(C(=O)NCC(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCNC(=N)N)C(=O)NC(CO)C(=O)N1CCCC1C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(CCCNC(=N)N)C(=O)NC(C(=O)NC(C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CC(C)C)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCNC(=N)N)C(=O)NC(CC(N)=O)C(=O)NCC(=O)NC(CCCCN)C(=O)O)C(C)C)C(C)C)C(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Peng Y Zhu FZ Chen ZXet al.Characterization of myelin oligodendrocyte glycoprotein (MOG)35-55-specific CD8+ T cells in experimental autoimmune encephalomyelitis[J].Chin Med J (Engl). 2019 Dec 20;132(24):2934-2940.
molnova catalog
related products
-
2-Deoxokanshone L
2-Deoxokanshone L
-
MSH-B
MSH-B
-
IRAK4-IN-4
IRAK4-IN-4 inhibits cyclic GMP-AMP synthase (cGAS) with an IC50 of 2.1 nM.IRAK4-IN-4 is an interleukin-1 receptor–associated kinase 4 (IRAK4) inhibitor, has an IC50 of 2.8 nM.
